Shafagoj Yanal A, Naffa Randa G, El-Khateeb Mohammed S, Abdulla Yazeed L, Al-Qaddoumi Aseem A, Khatib Faisal A, Al-Motassem Yousef F, Al-Khateeb Eman M
Department of Physiology and Biochemistry, Faculty of Medicine, The University of Jordan, Amman, Jordan. E-mail:
Neurosciences (Riyadh). 2018 Jan;23(1):29-34. doi: 10.17712/nsj.2018.1.20170169.
To investigate the frequencies of the apolipoprotein E (APOE) alleles and genotypes and study their relationship with the lipid profile in Jordanian patients with late-onset Alzheimer`s disease (AD).
This case-control study was carried out on 71 Jordanian individuals: 38 patients with late-onset AD (age >/=65 years) and 33 age-matched healthy controls. All participants were recruited from senior homes and Jordan University Hospital, Amman, Jordan between January 2010 and December 2013. Each sample was examined for APOE`s 3 major isoforms (e2, e3, e4) using the polymerase chain reaction technique (PCR) followed by the sequencing technique. In addition, samples were screened for lipid profiles (total cholesterol (TC), high-density lipoprotein (HDL), lower-density lipoprotein (LDL), and triglyceride (TG) levels.
The e3/e4 genotype and e4 allele prevalence were higher in AD patients compared to healthy controls (26.3% vs. 3.0%, p=0.03 and 15.8% vs. 4.5%, p=0.03; respectively). In the AD group, the e2 carriers showed the lowest levels of total and LDL cholesterol, and the e4 carriers showed the highest levels of total and LDL cholesterol, although the difference was not statistically significant (p>0.05).
APOE-e4 frequency was almost 4 times higher in the AD group compared to the control group, and this difference was statistically significant. A trend that was observed in the AD group regarding the lipid profile and e2 and e4 carriers requires further investigation using a larger sample size.
研究约旦晚发性阿尔茨海默病(AD)患者载脂蛋白E(APOE)等位基因和基因型的频率,并探讨其与血脂谱的关系。
本病例对照研究纳入了71名约旦人:38例晚发性AD患者(年龄≥65岁)和33名年龄匹配的健康对照。所有参与者于2010年1月至2013年12月期间从约旦安曼的养老院和约旦大学医院招募。使用聚合酶链反应技术(PCR)随后进行测序技术对每个样本检测APOE的3种主要异构体(e2、e3、e4)。此外,对样本进行血脂谱(总胆固醇(TC)、高密度脂蛋白(HDL)、低密度脂蛋白(LDL)和甘油三酯(TG)水平)筛查。
与健康对照相比,AD患者中e3/e4基因型和e4等位基因的患病率更高(分别为26.3%对3.0%,p = 0.03;15.8%对4.5%,p = 0.03)。在AD组中,e2携带者的总胆固醇和LDL胆固醇水平最低,e4携带者的总胆固醇和LDL胆固醇水平最高,尽管差异无统计学意义(p>0.05)。
AD组中APOE - e4频率比对照组高近4倍,且这种差异具有统计学意义。AD组中观察到的关于血脂谱以及e2和e4携带者的趋势需要使用更大样本量进一步研究。